{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:41:26Z","timestamp":1790430086943,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.humpath.2020.11.005","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T10:57:19Z","timestamp":1605956239000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Genomic analysis in myeloid sarcoma and comparison with paired acute myeloid leukemia"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-1711","authenticated-orcid":false,"given":"Nancy Y.","family":"Greenland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Van Ziffle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-9640","authenticated-orcid":false,"given":"Yen-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxia","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-3836","authenticated-orcid":false,"given":"Sonam","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5967-5190","authenticated-orcid":false,"given":"Linlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.11.005_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1309\/AJCP1ZA7HYZKAZHS","article-title":"Myeloid sarcoma: extramedullary manifestation of myeloid disorders","volume":"132","author":"Campidelli","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.11.005_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3960\/jslrt.56.130","article-title":"Isochromosome 17q; A novel finding in myeloid sarcoma","volume":"56","author":"de Mel","year":"2016","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.humpath.2020.11.005_bib3","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/leu.2015.81","article-title":"Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma","volume":"29","author":"Li","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2020.11.005_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2016-10-743849","article-title":"Dermal myeloid sarcoma as an initial presentation of acute myeloid leukemia","volume":"129","author":"Daneshbod","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2020.11.005_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1096-911X(199809)31:3<144::AID-MPO3>3.0.CO;2-B","article-title":"Granulocytic sarcoma in children with acute myeloblastic leukemia and t(8;21","volume":"31","author":"Schwyzer","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.humpath.2020.11.005_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1309\/AJCPO58YWIBUBESX","article-title":"Extramedullary manifestations of myeloid neoplasms","volume":"144","author":"Wilson","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.11.005_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2020.11.005_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/gcc.20239","article-title":"Genomic profiling of myeloid sarcoma by array comparative genomic hybridization","volume":"44","author":"Deeb","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2020.11.005_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41408-018-0083-6","article-title":"RTK-RAS pathway mutation is enriched in myeloid sarcoma","volume":"8","author":"Choi","year":"2018","journal-title":"Blood Canc J"},{"key":"10.1016\/j.humpath.2020.11.005_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.humpath.2020.11.005_bib11","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1080\/10428190600967196","article-title":"Granulocytic sarcoma: 32 cases and review of the literature","volume":"47","author":"Paydas","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2020.11.005_bib12","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3109\/10428194.2014.963080","article-title":"Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis","volume":"56","author":"Movassaghian","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2020.11.005_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10245332.2017.1333275","article-title":"Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years","volume":"23","author":"Kaur","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.humpath.2020.11.005_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2141.2004.05124.x","article-title":"FLT3 mutations in myeloid sarcoma","volume":"126","author":"Ansari-Lari","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2020.11.005_bib15","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.leu.2404699","article-title":"Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas","volume":"21","author":"Falini","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2020.11.005_bib16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1080\/10428194.2016.1225208","article-title":"Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing","volume":"58","author":"Pastoret","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2020.11.005_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10428194.2017.1339879","article-title":"Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing","volume":"59","author":"Kashofer","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2020.11.005_bib18","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN cancer research group trials, 1980-2008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2020.11.005_bib19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jmoldx.2019.11.004","article-title":"Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival","volume":"22","author":"Werstein","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2020.11.005_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/his.13864","article-title":"Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia","volume":"75","author":"Ullman","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.11.005_bib21","first-page":"523168","article-title":"Myeloid sarcoma: clinicopathologic, cytogenetic, and outcome analysis of 21 adult patients","volume":"2011","author":"Al-Khateeb","year":"2011","journal-title":"Leuk Res Treatment"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720302331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720302331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:37:52Z","timestamp":1758645472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720302331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":21,"alternative-id":["S0046817720302331"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.11.005","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic analysis in myeloid sarcoma and comparison with paired acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}